Advancing strategies to target astrocytes for the treatment and prevention of neuro-disorders.
There have been few discoveries leading to drug treatments for brain diseases in recent decades and alternative avenues of investigation are urgently needed.
The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.
Wyss Center appoints Dr. Craig Cook as new Head of Business Development and LicensingWyss Center
Wyss Center partners with ALBA network
The Wyss Center partners with the ALBA Network to raise awareness and advocate for increased equity, inclusion and visibility of scientists from underrepresented groups in brain research.Collaboration
Wyss Center Geneva appoints Erwin Böttinger as new Chief Executive Officer
The appointment follows a funding commitment of CHF 120 million from the Wyss Foundation to further strengthen the Center’s mission to accelerate innovative therapies to the clinic to transform the lives of people with brain disorders.Wyss Center